 Pavel Jedlicka
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Ewing | 10 | 2023 | 100 | 3.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 6 | 2024 | 62 | 2.890 |
Why?
| | Oncogene Proteins, Fusion | 7 | 2024 | 206 | 1.920 |
Why?
| | Rhabdomyosarcoma | 3 | 2024 | 74 | 1.630 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 2 | 2024 | 25 | 1.560 |
Why?
| | MicroRNAs | 5 | 2017 | 678 | 1.140 |
Why?
| | Bone Neoplasms | 5 | 2017 | 248 | 1.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2024 | 1388 | 1.020 |
Why?
| | RNA-Binding Protein EWS | 5 | 2023 | 26 | 0.960 |
Why?
| | PAX3 Transcription Factor | 2 | 2024 | 17 | 0.900 |
Why?
| | Epigenesis, Genetic | 4 | 2024 | 648 | 0.840 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 5 | 2023 | 25 | 0.750 |
Why?
| | Chromatin | 1 | 2024 | 517 | 0.670 |
Why?
| | Forkhead Box Protein O1 | 1 | 2020 | 33 | 0.660 |
Why?
| | Cell Line, Tumor | 10 | 2024 | 3404 | 0.660 |
Why?
| | Epigenomics | 2 | 2017 | 117 | 0.600 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 407 | 0.590 |
Why?
| | Receptor, ErbB-4 | 1 | 2017 | 19 | 0.540 |
Why?
| | PTEN Phosphohydrolase | 1 | 2015 | 163 | 0.410 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2015 | 369 | 0.390 |
Why?
| | Somatomedins | 1 | 2011 | 27 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2010 | 56 | 0.320 |
Why?
| | Down-Regulation | 3 | 2017 | 635 | 0.310 |
Why?
| | Neoplasms | 2 | 2019 | 2712 | 0.250 |
Why?
| | Humulus | 1 | 2025 | 6 | 0.240 |
Why?
| | Stem Cells | 1 | 2010 | 598 | 0.240 |
Why?
| | Retroelements | 1 | 2025 | 48 | 0.230 |
Why?
| | Heterografts | 2 | 2017 | 135 | 0.230 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2025 | 114 | 0.230 |
Why?
| | Centromere | 1 | 2025 | 59 | 0.230 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 46 | 0.220 |
Why?
| | Promoter Regions, Genetic | 2 | 2020 | 1237 | 0.210 |
Why?
| | Animals | 7 | 2024 | 37151 | 0.180 |
Why?
| | Homeodomain Proteins | 2 | 2023 | 506 | 0.180 |
Why?
| | Muscle Development | 1 | 2022 | 115 | 0.170 |
Why?
| | Base Sequence | 2 | 2017 | 2180 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2013 | 329 | 0.160 |
Why?
| | Humans | 13 | 2024 | 138102 | 0.150 |
Why?
| | Mice | 4 | 2024 | 17769 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 189 | 0.150 |
Why?
| | Zebrafish Proteins | 1 | 2022 | 288 | 0.150 |
Why?
| | Signal Transduction | 1 | 2011 | 5068 | 0.140 |
Why?
| | Cell Proliferation | 2 | 2017 | 2472 | 0.140 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.140 |
Why?
| | CD146 Antigen | 1 | 2017 | 42 | 0.130 |
Why?
| | 3' Untranslated Regions | 1 | 2017 | 145 | 0.130 |
Why?
| | Sequence Alignment | 1 | 2017 | 360 | 0.130 |
Why?
| | Mice, SCID | 1 | 2017 | 368 | 0.120 |
Why?
| | RNA Interference | 1 | 2017 | 468 | 0.120 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 597 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 621 | 0.110 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 664 | 0.110 |
Why?
| | Transcriptome | 1 | 2020 | 969 | 0.110 |
Why?
| | Transcription Factors | 1 | 2022 | 1709 | 0.100 |
Why?
| | Clone Cells | 1 | 2013 | 263 | 0.100 |
Why?
| | Cell Movement | 1 | 2017 | 971 | 0.100 |
Why?
| | Mice, Nude | 1 | 2013 | 690 | 0.090 |
Why?
| | Phenotype | 1 | 2020 | 3158 | 0.090 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2012 | 166 | 0.090 |
Why?
| | Child | 3 | 2023 | 21990 | 0.080 |
Why?
| | Gene Silencing | 1 | 2011 | 197 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 844 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1755 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 758 | 0.080 |
Why?
| | Soft Tissue Neoplasms | 1 | 2010 | 115 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2125 | 0.070 |
Why?
| | Chromosomes, Plant | 1 | 2025 | 13 | 0.060 |
Why?
| | Chromosome Segregation | 1 | 2025 | 46 | 0.060 |
Why?
| | Meiosis | 1 | 2025 | 84 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1487 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1477 | 0.060 |
Why?
| | Integrins | 1 | 2023 | 95 | 0.050 |
Why?
| | Myogenin | 1 | 2022 | 16 | 0.050 |
Why?
| | MyoD Protein | 1 | 2022 | 35 | 0.050 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 22 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 310 | 0.040 |
Why?
| | Adolescent | 1 | 2017 | 21637 | 0.030 |
Why?
| | Zebrafish | 1 | 2022 | 500 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2022 | 1999 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2586 | 0.030 |
Why?
| | Etoposide | 1 | 2012 | 160 | 0.020 |
Why?
| | Doxorubicin | 1 | 2012 | 338 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1130 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2012 | 796 | 0.020 |
Why?
|
|
Jedlicka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|